management of metastasis bone disease

29
Dr. Achmad Basuki, Sp. OT SMF Orthopaedi, Dharmais cancer center Hospital, Jakarta

Upload: indonesian-journal-of-cancer

Post on 29-Dec-2014

99 views

Category:

Documents


1 download

DESCRIPTION

Management of Metastasis Bone Disease, Dr. Achmad Basuki, Sp. OT - SMF Orthopaedi, Dharmais Cancer Center Hospital, Jakarta

TRANSCRIPT

Page 1: Management of Metastasis Bone Disease

Dr. Achmad Basuki, Sp. OT

SMF Orthopaedi, Dharmais cancer center Hospital, Jakarta

Page 2: Management of Metastasis Bone Disease

The most common cause of a destructive lesion of skeletal in adult

More than Primary sarcoma of the boneThe skeleton is the third most common

target of metastatic cancer can be one of the earliest sites affectedWhich produces the greatest morbidity

- loss of functionality- loss of quality of life- decreased survival

Page 3: Management of Metastasis Bone Disease

The role of the orthopedist are

- to establish or confirm diagnosis

- to evaluate for risk of fracture or

impending fracture

- to stabilize or other wish surgical

treatment pathological fracture

Page 4: Management of Metastasis Bone Disease
Page 5: Management of Metastasis Bone Disease
Page 6: Management of Metastasis Bone Disease

Batson’s vertebra vein

plexus

The most common

site of bone

metastasis

Page 7: Management of Metastasis Bone Disease

Osteolytic

• Bone destruction is

mediated by osteoclasts

in patients with either

breast cancer or

multiple myeloma

Osteoblastic

• Excess bone formation is

mediated by osteoblasts

in patients with either

prostate or breast cancer

Mundy GR. Nat Rev Cancer.

2002;8:584-593.

Page 8: Management of Metastasis Bone Disease
Page 9: Management of Metastasis Bone Disease

STROMAL CELL/

OSTEOBLAST

PRECURSOR

OSTEOCLAST

PTHr PCa ++

PO 4

Mature

Osteoclast

Bone Re-absorption

Differentiation

RANK L

RANK r

Page 10: Management of Metastasis Bone Disease
Page 11: Management of Metastasis Bone Disease

Pathologic Fractures

8-30%

Bone pain

50%

Spinal cord

compression

5%

Hypercalcemia 10%

Decrease Quality

of life and

Negative impact

on survival

Page 12: Management of Metastasis Bone Disease

Diagnosis

treatment

Page 13: Management of Metastasis Bone Disease

Bone scan

NormalLESION

X-Ray abnormal area

CT or MRI

MetastasisNormal

Biopsi ?

MetastasisBenign

Normal

Malignancy

Biopsi

BONE PAIN

Page 14: Management of Metastasis Bone Disease
Page 15: Management of Metastasis Bone Disease

Pain control

Inhibition of osteolysis

Handling complication

Page 16: Management of Metastasis Bone Disease

Non surgery

surgery

Page 17: Management of Metastasis Bone Disease

1. Pain Control

- Analgesics

- Radiation

- Chemotherapy

Page 18: Management of Metastasis Bone Disease

2. Inhibition of Osteolysis

- Bisphosphonates

Page 19: Management of Metastasis Bone Disease

• Bind to resorption sites

Bisphosphonateshave a strong

affinity for calcium phosphate

• Direct effects on osteoclasts

• Indirect effects via other cells

Bisphosphonatesinhibit bone resorption

• Recruitment of cells

• Adhesion to bone

• Lifespan of cells (increasing rates of apoptosis)

• Cellular activity

Bisphosphonatesdecrease 4

parameters of osteoclast function

Page 20: Management of Metastasis Bone Disease

3. Handling complication

Surgical management it has to

benefit improving life

quality

goal :

1. to provide local tumor control

2. immediate weight bearing & function

indications :

- for diagnosis

-prophylactic fixation of impending fractures

- stabilization of pathologic fracture

Page 21: Management of Metastasis Bone Disease

General consideration

• Life expectancy at least 6 to 12 week consider for surgical candidate

• Patient recovery time from surgery should not outlast estimated time survival

• Provide immediately stable reconstruction

• Scoring assessment to predict the surgical candidate

Page 22: Management of Metastasis Bone Disease

Tomita K,

Kawahara N, Kobayashi T, Yoshida A, Murakami H,

Akamaru T. Surgical strategy for spinal

metastases. Spine. 2001;26:298-306.)

Page 23: Management of Metastasis Bone Disease
Page 24: Management of Metastasis Bone Disease
Page 25: Management of Metastasis Bone Disease
Page 26: Management of Metastasis Bone Disease

Walker MP, Yaszemski MJ, Kim CW, Talac R, Currier BL.

Metastatic

disease of the spine: evaluation and treatment. Clin Orthop

Relat Res. 2003;415 Suppl:S165-75.

Page 27: Management of Metastasis Bone Disease
Page 28: Management of Metastasis Bone Disease
Page 29: Management of Metastasis Bone Disease